Addiction Treatment

Nexalin Technology Demonstrates Success in the Treatment of Depression

Nexalin Technology is pleased to announce the initiation of clinical trials designed by the University of Pennsylvania to investigate the effectiveness of the Nexalin transcranial stimulation (TACS) for major depressive disorder. A subsidiary of Legacy Ventures International Inc. (OTC PINK: LGYV), Nexalin Technology is an FDA cleared medical device company that utilizes a safe, non-invasive,

2017-11-09T18:59:24+00:00

Opioids: Unexpected recovery

Ramona Osborne often sat on the edge of death and dangled her feet over the side. Her story is one of being at the bottom of an opiate pit and finally clawing her way out. And now it’s sometimes a couple of months between hearing of a friend or a friend’s child lost to a

2017-11-05T21:33:15+00:00

Tennessee has taken concrete steps to battle the opioid crisis in the last few years.

The state repealed a law in 2015 called The Intractable Pain Act. That law said a doctor who refused to prescribe opioids to patients who requested the treatment was legally obligated to inform the patient of a physician who specialized in the treatment of severe chronic pain with methods that included opioids. New laws were

2017-10-28T21:14:56+00:00

Leading BC Drug Rehab & Alcohol Treatment Program, SCHC Announces Article on Addiction by Dr. Geoff Thompson

VANCOUVER, Canada - October 27, 2017 - (Newswire.com) Sunshine Coast Health Centre (https://www.sunshinecoasthealthcentre.ca), long deemed one of the top drug rehabilitation and alcohol treatment programs in British Columbia, Canada, is excited to announce that the Centre's Dr. Geoff Thompson has published an important article entitled, "Who am I? The Question Addicts Don't Ask" in Zest

2017-10-28T21:04:54+00:00